Aligos Therapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 145
Rang # Quantité totale PI 8 959
Note d'activité PI 3,1/5.0    186
Rang # Activité PI 3 689
Symbole boursier ALGS (nasdaq)
ISIN US01626L1052
Capitalisation 102M  (USD)
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

52 1
33 0
57 0
2
 
Dernier brevet 2025 - Methods and compositions for tar...
Premier brevet 2019 - S-antigen transport inhibiting o...
Dernière marque 2020 - STOPS
Première marque 2018 - ALIGOS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Methods and compositions for targeting pd-l1. The present disclosure related to compounds that ca...
Invention Methods and compositions for targeting pd-l1. The present disclosure related to compounds that c...
Invention Short interfering nucleic acid (sina) molecules targeting angptl 3 and angptl 8 and methods of us...
Invention Modified short inerfering nucleic acid (sina) molecules and uses thereof. OO-methyl nucleotides a...
Invention Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof. Disclosed herein are s...
Invention Hepatitis b combination therapies. Provided herein are methods of treating a hepatitis B viral an...
Invention Methods and compostitions for targeting pd-l1. The present disclosure related to compounds that ...
2023 Invention Anti-viral compounds. Provided herein are compounds of Formula (I), or pharmaceutically acceptab...
Invention Anti-viral compounds. Provided herein are compounds of Formula (I), or pharmaceutically acceptabl...
Invention Modified short interfering nucleic acid (sina) molecules and uses thereof. Described are short in...
Invention Bicyclic compounds. Provided herein are compounds of Formula (I), or pharmaceutically acceptable...
Invention Bicyclic compounds. Provided herein are compounds of Formula (I), or pharmaceutically acceptable ...
Invention Pyrrole compounds. Provided herein are compounds of Formula (I), or pharmaceutically acceptable ...
Invention Modified short interfering nucleic acid (sina) molecules and uses thereof. Disclosed herein are s...
Invention Pyridazinone and methods of use thereof. Disclosed herein are methods of modulating the activity...
Invention Modified gapmer oligomers and methods of use thereof. The disclosure includes antisense oligonuc...
Invention Modified gapmer oligomers and methods of use thereof. The disclosure includes antisense oligonucl...
2022 Invention Splice switch oligonucleotide (sso) molecules for targeting β-catenin and uses thereof. The prese...
Invention Short interfering nucleic acid (sina) molecules for targeting β-catenin and uses thereof. The pre...
Invention Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections. Provided h...
Invention Modified short interfering nucleic acid (sina) molecules and uses thereof. Disclosed herein are ...
Invention Modified short interfering nucleic acid (sina) molecules and uses thereof. OO-methyl nucleotides ...
Invention Modified short interfering nucleic acid (sina) molecules and uses thereof. Described are short i...
2020 P/S Oligonucleotides; nucleic acids. Pharmaceutical preparations, namely, antivirals; pharmaceutical ...
2018 P/S Product research and development; scientific research and development in the field of pharmaceuti...